Head of Corporate Development @ (March 2024 - October 2025)
Vice President of Business Development @ (July 2022 - March 2024)
Vice President Of Business Development @ (January 2022 - July 2022)
Senior Director Business Development @ (January 2019 - January 2022)
Director, Business Development @ (January 2017 - January 2019)
Associate Director, Business Development and Commercial Planning @ (January 2015 - January 2017)
Engagement Manager @ (January 2013 - January 2015)
Consultant @ (January 2011 - January 2012)
Product Engineer II @ (January 2007 - January 2010)
Kyle Dow Education
The Wharton School
Master of Business Administration (M.B.A.)
2010-2012
Rensselaer Polytechnic Institute
Bachelor’s Degree (Biomedical Engineering)
Kyle Dow Skills
Biomedical Engineering
Biotechnology
Business Strategy
Competitive Analysis
Corporate Development
Cross-functional Team Leadership
Data Analysis
Financial Modeling
Lifesciences
Medical Devices
Product Development
Product Management
R&D
Start-ups
Strategy
Start Ups
Cross Functional Team Leadership
Cross Functional Team
Kyle Dow Summary
Kyle Dow, based in Boston, MA, US, is currently a Chief Financial Officer at Skyhawk Therapeutics. Kyle Dow brings experience from previous roles at Skyhawk Therapeutics, Innoviva Specialty Therapeutics, Inc. and Entasis Therapeutics. Kyle Dow holds a 2010 - 2012 Master of Business Administration (M.B.A.) @ The Wharton School. With a robust skill set that includes Biomedical Engineering, Biotechnology, Business Strategy, Competitive Analysis, Corporate Development and more. Kyle Dow has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Kyle Dow?
Find contact details for 700 million professionals.